Skip to content
MarketScale
‹ Back to IndustriesHealthcare

How Healthcare Worker Shortages are Contributing to a Challenging Flu and RSV Season

Is the U.S. prepared for a healthcare emergency this winter? A shortage of healthcare providers is setting the stage for a crisis. Indicators show this year’s flu season will be pretty severe, and the RSV season, which typically occurs between late December to Mid-February, is already showing signs of case spikes. Rachell Neill, Co-Founder…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Start free

Is the U.S. prepared for a healthcare emergency this winter? A shortage of healthcare providers is setting the stage for a crisis. Indicators show this year’s flu season will be pretty severe, and the RSV season, which typically occurs between late December to Mid-February, is already showing signs of case spikes.

Rachell Neill, Co-Founder of Carex Consulting Group, says this combination of flu and RSV cases, on top of a lingering pandemic, is burning out healthcare workers.

“What it’s doing is taking a post-pandemic workforce and putting them back into a position of needing flexibility. It’s especially going to impact primary caregivers because if children get sick and are unable to go to school, they’re more likely to have a severe illness, so if they get the flu and that gets coupled with RSV, there’s a higher likelihood of hospitalization.

Each year the CDC estimates 2.1 million outpatient visits among children younger than five years old due to RSV and 58,000-80,000 hospitalizations.

“It’s going to put a strain on our health systems, the healthcare workers, and the parents or primary caregivers that are working,” Neill says. “We will also see an impact on companies now requiring workers to return to the office.”

Worker burnout is a genuine concern in the healthcare industry, and healthcare systems and communities are working to help alleviate some of the strains. These issues may benefit from loan forgiveness programs to technology automation solutions that increase efficiency and reduce work overload, but challenges remain.

If the situation remains, the U.S. will have a predicted nursing shortage of between 200,000 and 450,000 RNs by 2025. That will result in a 10 to 20 percent nursing gap to-patient ratio as patient needs increase and the number of new nurses decreases. The AAMC projects primary care physician shortages between 17,800 and 48,000 and non-primary care physician shortages between 21,000 and 77,100 by 2034.

How can healthcare increase its workforce and take seasonal healthcare challenges head-on? The American Hospital Association lists several steps, which include: congress passing legislative priorities to stimulate job growth in the healthcare sector, lifting the cap on Medicare residency positions to enhance access to care, and helping America’s hospitals better meet the needs of the communities they serve, supporting the Future Advancement of Academic Nursing Act, and regulating anti-competitive pricing practices of nurse staffing agencies, which have led to many nurses leaving full-time positions within hospital networks.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Healthcare Insights

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly has broken ground on a $6.5 billion manufacturing facility in Houston, slated for completion around 2030. While attention has focused on scaling production of Foundayo, its oral GLP-1 treatment, the project also reflects broader U.S. efforts to rebuild domestic pharmaceutical manufacturing and highlights the supply chain challenge of forecasting demand and building capacity years in advance.

  • 01Eli Lilly commits $6.5 billion to a Houston pharmaceutical manufacturing facility due for completion around 2030, one of the largest single U.S. pharma production investments in recent years
  • 02GLP-1 demand forecasting remains highly uncertain, making it difficult to commit billions to manufacturing capacity years before demand and required output are clear.
  • 03Houston's selection reflects industrial capacity and workforce depth, positioning the region as a biomanufacturing corridor and creating long-term hiring demand in engineering, quality control, and skilled trades

Sep 21, 2026

NextGen Invent’s Deepak Mittal argues for scoped healthcare AI pilots with early governance

NextGen Invent’s Deepak Mittal argues that healthcare AI pilots can begin with a reliable data subset and early governance. His performance figures are vendor claims, not independently verified results.

  • 01Deepak Mittal advocates starting with a defined problem and suitable data rather than waiting for perfect organization-wide data.
  • 02Some performance figures cited in the interview (for example, preparation time and model counts) are company-reported and not independently verified in this article.
  • 03NIST’s voluntary AI Risk Management Framework provides an independent structure for governance and risk evaluation.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512